Fabbri, Chiara
Kasper, Siegfried
Kautzky, Alexander
Zohar, Joseph
Souery, Daniel
Montgomery, Stuart
Albani, Diego
Forloni, Gianluigi
Ferentinos, Panagiotis
Rujescu, Dan
Mendlewicz, Julien
Uher, Rudolf
Lewis, Cathryn M. http://orcid.org/0000-0002-8249-8476
Serretti, Alessandro http://orcid.org/0000-0003-4363-3759
Funding for this research was provided by:
European Commission (793526)
Canada Research Chairs
DH | National Institute for Health Research
Article History
Received: 17 September 2019
Revised: 2 January 2020
Accepted: 10 January 2020
First Online: 3 February 2020
Conflict of interest
: D.S. D. has received grant/research support from GlaxoSmithKline and Lundbeck; has served as a consultant or on advisory boards for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, and Lundbeck. S.M. has been a consultant or served on Advisory boards: AstraZeneca, Bristol Myers Squibb, Forest, Johnson & Johnson, Leo, Lundbeck, Medelink, Neurim, Pierre Fabre, Richter. S.K. received grants/research support, consulting fees and/or honoraria within the last 3 years from Angelini, AOP Orphan Pharmaceuticals AG, Celegne GmbH, Eli Lilly, Janssen-Cilag Pharma GmbH, KRKA-Pharma, Lundbeck A/S, Mundipharma, Neuraxpharm, Pfizer, Sanofi, Schwabe, Servier, Shire, Sumitomo Dainippon Pharma Co. Ltd. and Takeda. J.Z. has received grant/research support from Lundbeck, Servier, Brainsway and Pfizer, has served as a consultant or on advisory boards for Servier, Pfizer, Abbott, Lilly, Actelion, AstraZeneca and Roche, and has served on speakers’ bureaus for Lundbeck, Roch, Lilly, Servier, Pfizer and Abbott. J.M. is a member of the Board of the Lundbeck International Neuroscience Foundation and of Advisory Board of Servier. A.S. is or has been consultant/speaker for: Abbott, Abbvie, Angelini, Astra Zeneca, Clinical Data, Boheringer, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, Servier. The other authors declare no conflict of interest. C,M.L. is a member of the R&D SAB of Myriad Neuroscience.